Tyler Lahusen

Medicine · Health Sciences

27h-index4.4kcitations54works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Sirtuins and Resveratrol in Medicine(11), Cancer-related Molecular Pathways(9), Microtubule and mitosis dynamics(8), Estrogen and related hormone effects(8), CRISPR and Genetic Engineering(8)

Publications54 total

Supplementary Figure 4 from SRT1720 Induces Lysosomal-Dependent Cell Death of Breast Cancer Cells
2023Open Access
Data from SRT1720 Induces Lysosomal-Dependent Cell Death of Breast Cancer Cells
2023Open Access
Supplementary Figure 3 from SRT1720 Induces Lysosomal-Dependent Cell Death of Breast Cancer Cells
2023Open Access
Supplementary Figure 1 from SRT1720 Induces Lysosomal-Dependent Cell Death of Breast Cancer Cells
2023Open Access
Supplementary Figure 1 from SRT1720 Induces Lysosomal-Dependent Cell Death of Breast Cancer Cells
2023Open Access
Supplementary Figure 3 from SRT1720 Induces Lysosomal-Dependent Cell Death of Breast Cancer Cells
2023Open Access
Supplementary Figure 5 from SRT1720 Induces Lysosomal-Dependent Cell Death of Breast Cancer Cells
2023Open Access
Data from SRT1720 Induces Lysosomal-Dependent Cell Death of Breast Cancer Cells
2023Open Access
Supplementary Figure 2 from SRT1720 Induces Lysosomal-Dependent Cell Death of Breast Cancer Cells
2023Open Access
Supplementary Figure 2 from SRT1720 Induces Lysosomal-Dependent Cell Death of Breast Cancer Cells
2023Open Access
Supplementary Figure 4 from SRT1720 Induces Lysosomal-Dependent Cell Death of Breast Cancer Cells
2023Open Access
Supplementary Figure 5 from SRT1720 Induces Lysosomal-Dependent Cell Death of Breast Cancer Cells
2023Open Access
Data from Epidermal Growth Factor Receptor Tyrosine Phosphorylation and Signaling Controlled by a Nuclear Receptor Coactivator, Amplified in Breast Cancer 1
2023Open Access
Data from Epidermal Growth Factor Receptor Tyrosine Phosphorylation and Signaling Controlled by a Nuclear Receptor Coactivator, Amplified in Breast Cancer 1
2023Open Access
Supplementary Methods and Figures 1-3 from Epidermal Growth Factor Receptor Tyrosine Phosphorylation and Signaling Controlled by a Nuclear Receptor Coactivator, Amplified in Breast Cancer 1
2023Open Access
Supplementary Methods and Figures 1-3 from Epidermal Growth Factor Receptor Tyrosine Phosphorylation and Signaling Controlled by a Nuclear Receptor Coactivator, Amplified in Breast Cancer 1
2023Open Access
Safety and durability of AGT103-T autologous T cell therapy for HIV infection in a Phase 1 trial
Frontiers in Medicine·2022· 8 citedOpen Access
Reducing farnesyl diphosphate synthase levels activates Vγ9Vδ2 T cells and improves tumor suppression in murine xenograft cancer models
Frontiers in Immunology·2022· 3 citedOpen Access
Preclinical Development and Clinical-Scale Manufacturing of HIV Gag-Specific, LentivirusModified CD4 T Cells for HIV Functional Cure
Molecular Therapy — Methods & Clinical Development·2020· 10 citedOpen Access
Gamma Delta T Cell Therapy for Cancer: It Is Good to be Local
Frontiers in Immunology·2018· 98 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Chu‐Xia Deng(24), Xiaoling Xu(13), Adrian M. Senderowicz(10), Athanassios Vassilopoulos(9), Edward A. Sausville(8), Cuiying Xiao(7), Anton Wellstein(7), Anna T. Riegel(7), Annabell S. Oh(6), Hyun‐Seok Kim(5), Rui-Hong Wang(5), David Gius(4), Ruihong Wang(4), C. David Pauza(4), Haishan Li(4), C-X Deng(4), Mark Fereshteh(4), Donna Headlee(3), Conrad Kunick(3), Mi‐Hye Lee(3)